News About: Pharm. Industry


Bona-S requests for proforma invoice of insurance drugs in trouble.

The actual purchasing price reimbursement system faced many difficulties from the public tenders invited by the national and public medical institutes for their purchase of insurance drugs at extremely lower prices. U...

Compensation for damage on dispute between Korean and Japanese companies.

Il Dong recently filed an arbitration to the Japanese International Commerce Arbitration Association (File No. 99-11) against Mitsubishi Tokyo Pharmaceutical Co. for settlement of the dispute on Arlnert. Il Dong ma...

Local franchise drug companies actively to tie up with foreign drug firms.

To prepare forthcoming new market environmental changes possibly caused by the implementation of medical and pharmacy separation system as scheduled from July 1, many local hospital sales oriented drug companies and f...

Daewoong and Samyangsa on strategic tie-up.

Daewoong and Samyangsa made a strategic business tie-up on Jan. 21 for the production and the marketing of the patch type of drugs, aiming at a synergic effect by both parties who may intensify and exchange their powe...

Drug industry just to wait and see for M&A fever prevailed in overseas.

While the foreign multinational drug corporations were in an M&A turmoil for their survival in the world markets, the domestic drug industry seemed to make any movement for such external environmental challenges. Dur...

Domestic and multinational drug corporations on hot struggles for survival.

A battle for the pharmaceutical market share between domestic and foreign multinational drug companies has shown a fearful competition for survival, which was more accelerated by a brisk movement of local companies' R...

Drug industry on hot head-hunting for sales.

Recently many help-wanted advertising by drug companies for sales area appeared on the public mass media after Dec. last year, indicating a favorable trend of once ailing industry after the IMF economic turmoil. K...

Drug makers and franchise companies to vie with each other for new drug markets.

The drug manufacturers and the drug franchise companies are struggling hard to multiply their sales in the retail pharmacy markets to cope with the forthcoming implementation of the medical and pharmacy separation pla...

Franchise chain drug stores to introduce 400 new products.

To cope with the upcoming new market environmental changes under the government medical and phamacy separation plan as scheduled to launch from July 1, for which the retail pharmacy community feared to bring out a pos...

Domestic biotech products on rapid growth in the market.

The domestic bio-technological products grew up rapidly, showing a consistent increasing curve by annual 32.1% hikes on average probably until year 2003, predicted by the KEIT study report. According to the researc...

TOP
BACK
Address: 295-1, Chungpa-Ro, Yongsan-Gu, Korea
Phone: 02-3270-0114 | Fax: 02-3270-0129 | Email: eyd@yakup.com

Copyright © Yakup Shinmoon, Inc. All Rights Reserved.